These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29442453)

  • 1. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
    Roszak J; Smok-Pieniążek A; Stępnik M
    Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway.
    Roszak J; Smok-Pieniążek A; Nocuń M; Stępnik M
    Chem Biol Interact; 2013 Oct; 205(3):198-211. PubMed ID: 23911876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
    Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
    Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway.
    Yingchun L; Xiujuan Q; Jinglei Q; Ye Z; Jing L; Yuee T; Xuejun H; Kezuo H; Yunpeng L
    Braz J Med Biol Res; 2011 Feb; 44(2):105-11. PubMed ID: 21180886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
    J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.
    Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takeuchi J; Toyoda H
    Oncol Rep; 2013 Jun; 29(6):2362-8. PubMed ID: 23563754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
    Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
    Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
    Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
    Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
    J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
    Bornhauser BC; Bonapace L; Lindholm D; Martinez R; Cario G; Schrappe M; Niggli FK; Schäfer BW; Bourquin JP
    Blood; 2007 Sep; 110(6):2084-91. PubMed ID: 17537996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide and the phosphoinositide 3-kinase/akt pathway in chronic lymphocytic leukemia.
    Goussetis DJ; Platanias LC
    Clin Cancer Res; 2010 Sep; 16(17):4311-2. PubMed ID: 20622048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
    Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
    Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
    Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
    Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.